A hospital-based cohort study found sex heterogeneity in the severity of osteoarthritis symptoms in type 2 diabetes, and an association between insulin treatment and pain severity in men.
Short sleep duration is associated with lower bone mineral density (BMD) and a higher risk for osteoporosis among postmenopausal women.
Contrary to expectations, the prevalence of cannabis use disorder (CUD) decreased significantly among individuals reporting daily/almost daily cannabis use between 2002 and 2016.
Persons with rheumatoid arthritis (RA) commonly use glucocorticoids to manage their disease. Study authors seek to determine how providers prescribe glucocorticoids to commercially insured, newly diagnosed patients with RA in the United States.
This study was the first to evaluate both the prevalence of osteopenia and osteoporosis in a large cohort of patients with bronchiectasis and its relationship with other variables, including clinical, body composition and bone turnover, and inflammation markers.
Researchers evaluated grey scale ultrasound and power Doppler ultrasound synovitis to predict joint damage progression in rheumatoid arthritis.
Ixekizumab demonstrated superiority to adalimumab in achieving simultaneous joint and skin improvement in biologic-naive patients with active psoriatic arthritis, according to data from the phase 3b/4 SPIRIT Head-to-Head (H2H) study.
For patients with psoriatic arthritis (PsA), the age of psoriasis onset determines whether arthritis or psoriasis starts first.
Researchers reported on the efficacy and safety of 300 mg or 150 mg secukinumab in managing axial manifestations in patients with psoriatic arthritis.
In a phase 3 study, researchers assessed the efficacy and safety of ixekizumab in patients with active nonradiographic axial spondyloarthritis.